Rosuvastatin in the Treatment of Rectal Cancer

NCT02569645 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

45

Enrollment

OTHER

Sponsor class

Conditions

Rectal Cancer

Interventions

DRUG: Rosuvastatin

Sponsor

AHS Cancer Control Alberta

Collaborators

[object Object]